Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Slick City and Activeon Accelerate European Expansion with New Parks in Sweden and Austria
GlobeNewswire, Inc.
CHESTERFIELD, Mo., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Slick City Franchise Group, the world’s first indoor slide and air court franchise, today announced plans to open new locations in Gothenburg, Sweden and Vienna, Austria, as the brand continues...
MyProMovers Provides Local and Long-Distance Moving Across Washington DC and the DMV
EIN Presswire
MyProMovers provides local and long-distance moving for residential and commercial customers across Washington DC, Northern Virginia, Maryland and the DMV. WASHINGTON, DC, UNITED STATES, September 11, 2026 /EINPresswire.com/ -- MyProMovers is a...
Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
GlobeNewswire, Inc.
Kensington, MD, USA and Munich/Martinsried, Germany, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Kensington, MD, USA, and Munich/Martinsried, Germany, September 11, 2026 – Galimedix Therapeutics, Inc. (“Galimedix”), a Phase 2 clinical-stage biotechnology...
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
GlobeNewswire, Inc.
FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB)...
Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand
GlobeNewswire, Inc.
Fireside chat featuring Bob Jahr, Chief Executive Officer, and H.C. Wainwright Managing Director & Senior Biotechnology Equity Research Analyst Access the video webcast here ISELIN, N.J., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics,...
Sole Searching: Why Foot Health May Be Wellness’s Next Longevity Frontier
EIN Presswire
Hotels and retreats worldwide are putting the feet front and center, as new research ties foot and lower-leg strength to healthy aging.
F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings
GlobeNewswire, Inc.
MANCHESTER, United Kingdom, Sept. 01, 2026 (GLOBE NEWSWIRE) -- F2G Ltd., today announced abstracts accepted for presentation at the MSGERC 2026 Biennial Meeting in September and ISPOR Europe 2026 in November.
Rediscovering Her Purpose for Health and Peaceː Dr. Yumi Kisaka Finds Leadership and Growth in Global Career Development Program
UN International Training and Research Center
Despite achieving many of the career goals she had set for herself, Yumi reached a point where she felt it was time to consider the next stage of her professional and personal growth.
Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium
GlobeNewswire, Inc.
-- Chiesi’s abstract presentations highlight clinical insights and patient-reported outcomes in Fabry disease and alpha-mannosidosis -- -- Rooted in patient voice and scientific rigor, this research reflects Chiesi’s long-standing role in...
CENTRAL EUROPE: Austria has reportedly resumed Dublin transfers to Italy ― Sharp increase in withdrawal of protection for Syrian refugees in Germany ― Evidence of growing anti-Ukrainian sentiment in Poland ― Court ruling paves way for return of some Af…
European Council on Refugees and Exiles (ECRE)
CENTRAL EUROPE: Austria has reportedly resumed Dublin transfers to Italy ― Sharp increase in withdrawal of protection for Syrian refugees in Germany ― Evidence of growing anti-Ukrainian sentiment in Poland ― Court ruling paves way for return of...
Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment
GlobeNewswire, Inc.
Access the segment here ISELIN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) for...
United Cerebral Palsy Celebrates the Heart of Support During DSP Recognition Week
EIN Presswire
September 13-19 campaign honors the dedicated, essential workforce that makes community living and inclusion possible for people with disabilities.
New Publication Demonstrates Disease-Modifying Potential of TELOBLOCK in Models of Idiopathic Pulmonary Fibrosis
EIN Presswire
VIENNA, AUSTRIA, August 20, 2026 /EINPresswire.com/ -- TAG Therapeutics a biotechnology company developing precision medicines for diseases driven by telomere dysfunction, today announces the publication of compelling preclinical data supporting...
George Medicines announces GMRx2 presentations at the European Society of Cardiology Congress 2026
GlobeNewswire, Inc.
London, UK, Boston, MA, 20 August 2026 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, today announced that data on GMRx2, its single pill low-dose combination...
Canada Steps Up to Support Global Cancer Care with First Contribution to IAEA’s Rays of Hope Initiative
GlobeNewswire, Inc.
TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The Canadian Nuclear Isotope Council (CNIC) today announced Canada’s first official contribution to the International Atomic Energy Agency’s (IAEA) Rays of Hope initiative, a global effort to expand...
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
GlobeNewswire, Inc.
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company”), a biotechnology company...
Seven RNA leaders launch the European RNA Alliance
EIN Presswire
The new alliance provides researchers, biotech and pharma with a gateway to complementary European RNA technologies and scientific expertise.
Nutrition May Help Support Nerve Health Alongside Diabetes Management, Specialists Say
EIN Presswire
Diabetic Nerve Clinic encourages patients to view healthy eating as part of a comprehensive approach to protecting nerve function.
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
GlobeNewswire, Inc.
LAS VEGAS, NEVADA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”) and Austrianova, its joint venture partner in Insulinova, today announced that Insulinova has entered into a Research and Option Agreement...
eHealth Exchange 2026 Annual Meeting To Spotlight Trust, AI, Future of Nationwide Interoperability
GlobeNewswire, Inc.
VIENNA, Va., Sept. 09, 2026 (GLOBE NEWSWIRE) -- eHealth Exchange™, one of the nation’s oldest and largest health information networks, today announces its 2026 annual meeting agenda.
Sign up for:
Austria Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.